- Details
- Description
Packaging Size:
30 tablets
Strength:
80 mg
Composition:
Osimertinib Mesylate INN
Treatment:
Anti-Cancer / Oncology
Form:
Tablet
Brand:
OSIKIN
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
OSIKIN (Osimertinib Mesylate INN) is an oral targeted anti-cancer medicine containing osimertinib, a third-generation EGFR tyrosine kinase inhibitor used to block abnormal EGFR signaling in cancer cells. It is primarily used for EGFR mutation-positive non-small cell lung cancer (NSCLC). OSIKIN is listed as an anti-cancer medicine with a 30-tablet pack size.
